EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical characteristics and prognosis of EBV-Positive mature B-Cell lymphoma in children: a retrospective study

Yuanyuan Hou, Yiwei Yan, Xiuli Zhu, Jian Chen, Yu Zheng, Yang Li, Wenting Zhang, Xiaofei Lu, Yuqiao Diao, Lian Jiang

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06506-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yuanyuan Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Medical University, Shijiazhuang, Hebei, P.R. China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Lymphoma, B-Cell. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science Research Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV)-associated pediatric mature B-cell lymphoma is characterized by rapid progression, a poor prognosis, and a high relapse rate. However, research on this condition remains limited. This retrospective study analyzed its clinical features and prognostic factors in children. Kaplan‒Meier analysis was performed to assess the impact of tumor EBV-encoded RNA (EBER)impact status on survival, and LASSO Cox regression was used to identify risk factors. The predictive performance of a model including the identified risk factors was assessed using calibration curves and receiver operating characteristic (ROC) curves. Tumor EBER status was significantly positively correlated with the EBV-DNA level (P < 0.05). EBER-positive pediatric patients presented elevated IgA levels, reduced IgG/IgM levels, decreased CD4 + T-cell counts, and increased CD8 + T-cell counts (P < 0.05). Compared with EBER-negative patients, EBER-positive patients had worse 5-year cumulative progression-free survival (PFS) (73.33%) and cumulative overall survival (OS) (78.30%) (P < 0.05). LASSO Cox regression analysis identified EBER (PFS HR 3.48, 95% CI 1.16-10.47, P = 0.027; OS HR 8.10, 95% CI 1.80-36.38, P = 0.006) and LDH (PFS HR 3.05, 95% CI 1.07-8.68, P = 0.037; OS HR 7.38, 95% CI 1.42-38.47, P = 0.018) as key prognostic markers. The model predicted 3-/5-year survival with high accuracy, with a C-index of 0.699 (95% CI: 0.558-0.841) for PFS and AUC (95% CI) values of 0.730 (0.575-0.886) and 0.691 (0.515-0.868). For OS, the C-index was 0.810 (95% CI: 0.669-0.952), and the AUC (95% CI) values were 0.805 (0.605-1.005) and 0.817 (0.618-1.015). Pediatric patients with EBV-associated mature B-cell lymphoma present distinct clinical and prognostic features that significantly influence the tumor immune microenvironment. The risk prognostic model based on tumor EBER status and LDH level reliably predicts outcomes in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanLymphoma, B-CellHumansRetrospective StudiesMaleChildFemaleChild, PreschoolAdolescentPrognosisRNA, Viral

Stichwörter der Autor:innen

ChildrenEBEREBV-DNAEBV-positive mature B-cell lymphomaLDH

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Hebei Medical University, Shijiazhuang, Hebei, P.R. China.
  • Department of Pediatrics, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.
  • Hebei Medical University, Shijiazhuang, Hebei, P.R. China. 46100280@hebmu.edu.cn.
  • Department of Pediatrics, The Fourth Hospital of Hebei Medical University, No.12, Jiankang Road, Shijiazhuang, Hebei, P.R. China. 46100280@hebmu.edu.cn.

Förderung

  • Medical Science Research Project of Hebei

Zitieren

APA

Hou, Y., Yan, Y., Zhu, X., Chen, J., Zheng, Y., Li, Y., Zhang, W., Lu, X., Diao, Y., & Jiang, L. (2025). Clinical characteristics and prognosis of EBV-Positive mature B-Cell lymphoma in children: a retrospective study. Annals of Hematology. https://doi.org/10.1007/s00277-025-06506-8

Vancouver

Hou Y, Yan Y, Zhu X, Chen J, Zheng Y, Li Y, et al. Clinical characteristics and prognosis of EBV-Positive mature B-Cell lymphoma in children: a retrospective study. Annals of Hematology. 2025. doi:10.1007/s00277-025-06506-8

BibTeX
@article{Hou2025,
  author = {Hou, Yuanyuan and Yan, Yiwei and Zhu, Xiuli and Chen, Jian and Zheng, Yu and Li, Yang and Zhang, Wenting and Lu, Xiaofei and Diao, Yuqiao and Jiang, Lian},
  title = {Clinical characteristics and prognosis of EBV-Positive mature B-Cell lymphoma in children: a retrospective study},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06506-8}
}
Kostenlos starten →